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This is the first description that we are aware of describing the spontaneous resolution of an acute pulmonary vasculitis, possibly
secondary to microscopic polyangiitis. Haemoptysis is a common symptom for patients presenting to primary and tertiary referral
centres, and pulmonary vasculitis is one of a variety of aetiologies that should always be considered. The pulmonary vasculitides
are diﬃcult diagnostic and management problems. They are encumbered by a relative paucity of level 1 evidence addressing their
diagnosis, classification, and treatment. This is therefore an important paper to publish because it adds to the global breadth of
experience with this important clinical condition.
In July 2010 a 43-year-old female presented with a 24-
hour history of 30mL of frank haemoptysis. There were no
symptoms suggestive of a respiratory infection. She worked
as an oﬃce manager and had no relevant occupational or
environmental exposures. She had ceased smoking ten years
previously having accumulated a ten-pack-year history. She
had hypertension treated with amlodipine and perimen-
strual migraines. Both parents and her brother were alive
without any significant medical diseases.
On presentation peripheral arterial oxygen saturation
was 85% on room air, respiratory rate was 24 per
minute, blood pressure was 200/100, and temperature was
38.5◦C. She remained afebrile thereafter. An ECG demon-
strated sinus rhythm, 100 beats per minute. A chest X-
ray demonstrated bilateral perihilar infiltrates. A CTPA
confirmed diﬀuse bilateral alveolar infiltrates (Figure 1).
No vascular filling defects were identified. Haemoglobin
was 99 g/L (115–160). MCV (mean cell volume) was 67 fL
(81–96), and the film was suggestive of iron deficiency.
White cell count was mildly elevated at 137/nL (3.5–11).
Other inflammatory markers were also mildly elevated.
ESR (erythrocyte sedimentation rate) was 29mm (<15).
CRP (C-reactive protein) was 68.1mgl/L (<8). Creatinine
was 65 µmol/L (50–100). Urea was 48 µmol/L (2.7–7.8).
Electrolytes were within normal limits. INR (international
normalised ratio) was 1.1 (0·9–1.2). APTT (activated partial
thromboplastin time) was 28 seconds (25–34). Testing for
antiglomerular basement membrane, antiuclear cytoplasmic
antibodies (cANCA and pANCA), antinuclear antibodies,
and extractable nuclear antigens (ENA) were all negative.
Rheumatoid factor was <10 IU/mL (<30). Several sputum
samples were sent. No pathogens were identified on stan-
dard bacterial and mycobacterial cultures. There was no
cytological evidence of malignancy. Urinalysis was normal.
Phase contrast microscopy was not performed as the red
cell count on several specimens was within normal limits.
Albumin/creatinine ratio was 17.7 g/mol creatinine (<3.5).
The patient was treated with benzylpenicillin and doxycy-
cline, and there was improved, but persisting haemoptysis.
On the third day the patient proceeded to fibre optic
bronchoscopy where no source of bleeding or endobronchial
abnormality was identified. A surgical lung biopsy was
subsequently performed. At the operation blood was noted
within the pleural space, the surface of the lung was oozing
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Figure 1: Coronal CT chest demonstrating bilateral perihilar
pulmonary infiltrates consistent with diﬀuse alveolar haemorrhage.
fresh blood, and the parenchyma was boggy. A wedge
biopsy was taken from the right middle lobe. Microscopy
demonstrated a widespread interstitial inflammatory process
centred on capillary sized vessels. There were associated
interstitial haemorrhage and fibrin deposition. Occasional
neutrophils and eosinophils were both observed. The disease
process was variable in intensity with propensity for diﬀerent
expression on either side of an interlobular septum. No
granulomata were identified. Special stains were negative for
fungal hyphae and Pneumocystis species (Figures 2 and 3).
A diagnosis of small vessel pulmonary vasculitis was made,
thought to be most consistent with microscopic polyangiitis.
The patient made an uneventful recovery from the
surgical procedure and the haemoptysis appeared to rapidly
spontaneously settle. Induction immunosuppression with
cyclophosphamide and high dose prednisolone was dis-
cussed. However, the patient declined. The patient was
therefore, discharged three days after the operation with close
outpatient surveillance arranged. Repeated clinical reviews
with an assessment of lung function, chest radiology, renal
function, and urinalysis demonstrated continued complete
resolution of pulmonary vasculitis. 12 months after her
initial presentation she remained well.
Pulmonary vasculitis should be considered in the diﬀer-
ential diagnosis of haemoptysis. Microscopic polyangiitis is
a small vessel systemic vasculitis that usually manifests with
glomerulonephritis. The lungs are involved in association in
approximately 20% to 30% of cases, with diﬀuse alveolar
haemorrhage in approximately 10% to 20% [1, 2]. It is
associated with pANCA in 90% of the cases [3]. It is rare
for this disease to present with diﬀuse alveolar haemorrhage
in isolation. Treatment recommendations are largely based
on historical data demonstrating poor prognosis for patients
with pauciimmune glomerulonephritis. No randomised
controlled trials have been performed for patients with pul-
monary haemorrhage. Many advocate aggressive immuno-
suppression in this clinical situation with a combination of
cyclophosphamide and high dose of prednisolone, with or
without plasma exchange [4]. Owing to the toxic eﬀects
of this regimen, diﬀerent strategies have been investigated,
and promising disease modifying and biological alternatives
Figure 2: Low power magnification of hematoxylin and eosin
stained lung biopsy demonstrating a pauci-immune small vessel
vasculitis.
Figure 3: High power magnification of hematoxylin and eosin
stained lung biopsy demonstrating a pauci-immune small vessel
vasculitis.
continue to emerge, both for induction and maintenance
immunosuppression.
Here we described the unusual case of small vessel
pulmonary vasculitis with spontaneous remission.Whilst the
histology is thought to favour a diagnosis of microscopic
polyangiitis, it is possible that an alternate diagnosis was
missed, for example, through sampling error. This case
highlights the diﬃculties applying guidelines to rare diseases,
particularly when presentations are atypical, as was the case
of this patient.
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